How many institutions held LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in Q4 2023?

29 institutional investors reported LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share for Q4 2023. Use the holders table for investor-level position and value details.

Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)

Q: What does CUSIP 51654W101 represent in this 13F holders report?

CUSIP 51654W101 is the security identifier for LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 51654W101

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 11,280,432
Total 13F shares: 1,155,318
Share change: +1,573
Total reported value: $4,944,504
Put/Call ratio: 200%
Price per share: $4.28
Number of holders: 29
Value change: +$6,767
Number of buys: 9
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 51654W101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	3.3%	367,454	$1,253,019	—	30 Sep 2023	13F
NewEdge Advisors, LLC	13F	Company	1.5%	170,031	$579,828	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.84%	95,036	$324,141	—	30 Sep 2023	13F
Carlson Capital, L.P.	13F	Company	0.84%	95,000	$323,950	—	30 Sep 2023	13F
CM Management, LLC	13F	Company	0.66%	75,000	$255,750	—	30 Sep 2023	13F
Redmond Asset Management, LLC	13F	Company	0.41%	46,506	$158,585	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.34%	38,100	$130,000	—	30 Sep 2023	13F
Pathway Financial Advisors LLC	13F	Company	0.29%	32,771	$111,749	—	30 Sep 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.27%	30,632	$104,455	—	30 Sep 2023	13F
HORIZON KINETICS ASSET MANAGEMENT LLC	13F	Company	0.27%	30,000	$102,300	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	0.25%	27,752	$94,634	—	30 Sep 2023	13F
UBS Group AG	13F	Company	0.24%	27,000	$92,070	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	0.23%	26,481	$90,300	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	0.18%	20,148	$68,705	—	30 Sep 2023	13F
Sigma Planning Corp	13F	Company	0.16%	18,125	$61,806	—	30 Sep 2023	13F
Meridian Wealth Management, LLC	13F	Company	0.15%	16,660	$56,811	—	30 Sep 2023	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.14%	15,368	$52,000	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.11%	12,593	$42,942	—	30 Sep 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	4,492	$15,318	—	30 Sep 2023	13F
WOLFF WIESE MAGANA LLC	13F	Company	0.02%	2,200	$7,502	—	30 Sep 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	1,857	$6,332	—	30 Sep 2023	13F
RHUMBLINE ADVISERS	13F	Company	0%	228	$777	—	30 Sep 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	200	$682	—	30 Sep 2023	13F
Allworth Financial LP	13F	Company	0%	100	$341	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	0%	9	$31	—	30 Sep 2023	13F
Qube Research & Technologies Ltd	13F	Company	0%	2	$7	—	30 Sep 2023	13F
Franklyn G. Prendergast	3/4/5	Director	— class O/S missing	3,200	—	—	04 Nov 2021	3/4/5

Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q4 2023

As of 31 Dec 2023, Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,155,318 shares. The largest 10 holders included VANGUARD GROUP INC, NewEdge Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, CM Management, LLC, CARLSON CAPITAL L P, COMMONWEALTH EQUITY SERVICES, LLC, RENAISSANCE TECHNOLOGIES LLC, Redmond Asset Management, LLC, HORIZON KINETICS ASSET MANAGEMENT LLC, and Pathway Financial Advisors LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.